Applied Genetic Technologies Corporation Company Profile (NASDAQ:AGTC)

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation logoApplied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AGTC
  • CUSIP:
Key Metrics:
  • Previous Close: $7.95
  • 50 Day Moving Average: $8.26
  • 200 Day Moving Average: $9.95
  • 52-Week Range: $18,083,000.00 - $6.07
  • Trailing P/E Ratio: 13.97
  • Foreward P/E Ratio: -10.80
  • P/E Growth: 0.00
  • Market Cap: $146.48B
  • Outstanding Shares: 18,083,000
  • Beta: 1.69
Profitability:
  • Net Margins: 22.20%
  • Return on Equity: 9.32%
  • Return on Assets: 5.88%
Debt:
  • Current Ratio: 2.80%
  • Quick Ratio: 2.80%
Additional Links:
Companies Related to Applied Genetic Technologies Corporation:

Analyst Ratings

Consensus Ratings for Applied Genetic Technologies Corporation (NASDAQ:AGTC) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $14.67 (81.07% upside)

Analysts' Ratings History for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
Show:
DateFirmActionRatingPrice TargetDetails
2/8/2017Cantor FitzgeraldSet Price TargetHold$15.00View Rating Details
2/9/2017Stifel NicolausLower Price TargetBuy$22.00 -> $18.00View Rating Details
2/9/2017WedbushReiterated RatingOutperform$15.00View Rating Details
2/9/2017BMO Capital MarketsLower Price TargetBuy$20.00 -> $14.00View Rating Details
11/9/2016Roth CapitalUpgradeNeutral -> Buy$12.00 -> $15.00View Rating Details
9/26/2016Janney Montgomery ScottUpgradeSell -> Neutral$11.00View Rating Details
9/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformView Rating Details
1/10/2016Chardan CapitalReiterated RatingBuy$25.00View Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017        
2/8/2017Q217$0.02$0.11$11.10 million$10.90 millionViewListenView Earnings Details
11/8/2016Q117($0.08)$0.20$10.21 million$11.80 millionViewListenView Earnings Details
9/12/2016Q416$0.07$0.15$12.10 millionViewListenView Earnings Details
5/9/2016Q3$0.05$0.11$12.98 million$12.00 millionViewN/AView Earnings Details
2/8/2016Q216($0.19)$0.17$8.76 million$12.20 millionViewN/AView Earnings Details
11/5/2015Q1($0.19)($0.53)$5.91 million$11.06 millionViewN/AView Earnings Details
9/10/2015Q415($0.41)($0.48)$0.71 millionViewN/AView Earnings Details
5/11/2015Q315($0.33)($0.38)$0.59 million$0.28 millionViewN/AView Earnings Details
2/11/2015Q215($0.39)($0.28)$0.65 millionViewN/AView Earnings Details
11/12/2014Q115($0.29)($0.34)$258.00 million$705.00 millionViewN/AView Earnings Details
9/26/2014Q414($0.35)($0.32)$0.12 millionViewN/AView Earnings Details
5/14/2014Q114($0.37)($25.45)$0.15 million$0.23 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
Current Year EPS Consensus Estimate: $0.47 EPS
Next Year EPS Consensus Estimate: $-0.75 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20162($0.02)$0.00($0.01)
Q1 20172($0.45)$0.09($0.18)
Q2 20172($0.04)($0.02)($0.03)
Q3 20172($0.14)$0.04($0.05)
Q4 20172($0.16)($0.06)($0.11)
Q1 20181($0.13)($0.13)($0.13)
Q2 20181$0.06$0.06$0.06
Q3 20181($0.29)($0.29)($0.29)
Q4 20181($0.65)($0.65)($0.65)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
Insider Ownership Percentage: 2.46%
Institutional Ownership Percentage: 56.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2016Ivana MagovcevicDirectorBuy3,000$9.63$28,890.00View SEC Filing  
11/1/2016Jeffrey D ChulayVPSell1,000$7.05$7,050.00View SEC Filing  
9/22/2016Mark S ShearmanInsiderBuy3,000$8.87$26,610.00View SEC Filing  
9/20/2016Stephen W PotterInsiderBuy1,400$8.89$12,446.00View SEC Filing  
9/19/2016Lawrence E BullockCFOBuy10,000$8.75$87,500.00View SEC Filing  
2/23/2015Plc GlaxosmithklineMajor ShareholderSell503,150$22.00$11,069,300.00View SEC Filing  
1/23/2015Daniel L MenichellaVPSell1,996$24.90$49,700.40View SEC Filing  
12/22/2014Daniel L MenichellaVPSell9,000$20.83$187,470.00View SEC Filing  
4/1/2014Interwest Partners Viii LpMajor ShareholderBuy75,376$12.00$904,512.00View SEC Filing  
4/1/2014Jill CarrollDirectorBuy103,762$12.00$1,245,144.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Applied Genetic Technologies Corporation (NASDAQ:AGTC)
DateHeadline
News IconIs The Sell-Side Predicting That Applied Genetic Technologies Corporation (NASDAQ:AGTC) Will Move Higher? - Winfield Review (NASDAQ:AGTC)
winfieldreview.com - February 16 at 3:28 PM
finance.yahoo.com logoAPPLIED GENETIC TECHNOLOGIES CORP Financials (NASDAQ:AGTC)
finance.yahoo.com - February 14 at 3:40 PM
tmcnet.com logoAGTC Selected as Top Company in the University of Florida's 2017 Gator100 (NASDAQ:AGTC)
it.tmcnet.com - February 10 at 8:53 PM
finance.yahoo.com logoSeattle Genetics (SGEN) Loss Wider than Expected in Q4, Revenues Miss (NASDAQ:AGTC)
finance.yahoo.com - February 10 at 3:51 PM
rttnews.com logoAGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban - RTT News (NASDAQ:AGTC)
www.rttnews.com - February 9 at 3:25 PM
marketexclusive.com logoAnalyst Activity – Wedbush Reiterates Outperform on Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Market Exclusive (NASDAQ:AGTC)
marketexclusive.com - February 9 at 3:25 PM
4-traders.com logoAPPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:AGTC)
www.4-traders.com - February 8 at 8:32 PM
tmcnet.com logoAGTC Announces Financial Results and Business Update for … (NASDAQ:AGTC)
www.tmcnet.com - February 8 at 8:32 PM
seekingalpha.com logoApplied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2017 Results - Earnings Call Transcript (NASDAQ:AGTC)
seekingalpha.com - February 8 at 8:32 PM
us.rd.yahoo.com logoAGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 (NASDAQ:AGTC)
us.rd.yahoo.com - February 8 at 8:32 PM
biz.yahoo.com logoAPPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:AGTC)
us.rd.yahoo.com - February 8 at 8:32 PM
biz.yahoo.com logoAPPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem (NASDAQ:AGTC)
us.rd.yahoo.com - February 8 at 8:32 PM
sg.finance.yahoo.com logoApplied Genetic Technologies posts 2Q profit (NASDAQ:AGTC)
sg.finance.yahoo.com - February 8 at 8:32 PM
biz.yahoo.com logoQ2 2017 Applied Genetic Technologies Corp Earnings Release - After Market Close (NASDAQ:AGTC)
biz.yahoo.com - February 8 at 3:29 PM
News IconFDA accepts Flexion’s NDA for osteoarthritis steroid injection (NASDAQ:AGTC)
www.massdevice.com - February 7 at 8:51 PM
News IconNew medical device rules from Indian regulators (NASDAQ:AGTC)
www.massdevice.com - February 7 at 1:27 AM
News IconApplied Genetic Technologies Corporation (NASDAQ:AGTC) likely to see 11% move on its earnings reaction day - Post Analyst (NASDAQ:AGTC)
postanalyst.com - February 6 at 3:27 PM
globenewswire.com logoAGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 8, 2017 - GlobeNewswire (press release) (NASDAQ:AGTC)
globenewswire.com - February 2 at 3:23 PM
finance.yahoo.com logoAGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 8, 2017 (NASDAQ:AGTC)
finance.yahoo.com - February 2 at 3:23 PM
News IconAre Analysts Forecasting a Near-Term Upswing For Applied Genetic Technologies Corporation (NASDAQ:AGTC)? - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - February 1 at 3:27 PM
News IconApplied Genetic Technologies partners with Bionic Sight (NASDAQ:AGTC)
www.healio.com - February 1 at 1:36 AM
News IconInvestor Watch on Shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) - The Tribune (NASDAQ:AGTC)
lakecitytribune.com - January 31 at 1:36 AM
News IconEarnings Take Center Stage; Analysts Weighing in on Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Aiken Advocate (NASDAQ:AGTC)
aikenadvocate.com - January 31 at 1:36 AM
News IconHigh Volatility Moving the Needle For Shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 30 at 3:34 PM
News IconAre Insiders Bumping Up Their Positions in Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 30 at 3:34 PM
News IconWhat Are the Numbers Saying About: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Gilbert Daily (NASDAQ:AGTC)
gilbertdaily.com - January 30 at 1:23 AM
investornewswire.com logoApplied Genetic Technologies Corporation (NASDAQ:AGTC) Records An Impact Score Of 70 - Investor Newswire (NASDAQ:AGTC)
www.investornewswire.com - January 28 at 3:22 PM
News IconAGTC, Bionic Sight Collaborate on Optogenetic Therapy and Device for Patients with Retinal Disease (NASDAQ:AGTC)
www.ophthalmologyweb.com - January 26 at 1:34 AM
us.rd.yahoo.com logo7:04 am Applied Genetic Technologies enters into a strategic research and development collaboration with Bionic Sight to develop an optogenetic therapy and device for visual deficits and blindness (NASDAQ:AGTC)
us.rd.yahoo.com - January 26 at 1:34 AM
News IconApplied Genetic Technologies Corporation (AGTC) Under Analyst Spotlight - UK Market News (NASDAQ:AGTC)
www.ukmarketnews.co.uk - January 24 at 3:44 PM
News IconWhat The Charts Are Saying About Applied Genetic Technologies Corporation (NASDAQ:AGTC) - The Tribune (NASDAQ:AGTC)
lakecitytribune.com - January 24 at 1:28 AM
News IconWhat is the Street Saying About Applied Genetic Technologies Corporation (NASDAQ:AGTC)? - Aiken Advocate (NASDAQ:AGTC)
aikenadvocate.com - January 24 at 1:28 AM
News IconAmplified Volatility Spotted in Shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 20 at 3:30 PM
News IconApplied Genetic Technologies Corporation (AGTC) Under Analyst ... - UK Market News (NASDAQ:AGTC)
www.ukmarketnews.co.uk - January 18 at 3:56 PM
News IconGearing Up For a Bull Run? Analysts Weigh in on Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 18 at 3:56 PM
News IconTracking Corporate Insiders: What Are They Doing With Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 16 at 8:26 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Applied Genetic Technologies Corporation (NASDAQ ... - Aiken Advocate (NASDAQ:AGTC)
aikenadvocate.com - January 16 at 3:25 PM
News IconAre There Catalysts to Propel This Stock Forward: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Prospect Journal (NASDAQ:AGTC)
prospectjournal.com - January 16 at 3:25 PM
News IconApplied Genetic Technologies Corp AGTC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:AGTC)
www.bioportfolio.com - January 15 at 8:24 PM
nasdaq.com logoAGTC to Present at Phacilitate Cell & Gene Therapy World 2017 - Nasdaq (NASDAQ:AGTC)
www.nasdaq.com - January 14 at 3:24 PM
News IconWill The Needle Move For Applied Genetic Technologies Corporation (NASDAQ:AGTC) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 13 at 1:28 AM
nasdaq.com logoImplied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options - Nasdaq (NASDAQ:AGTC)
www.nasdaq.com - January 13 at 1:28 AM
globenewswire.com logoAGTC to Present at Phacilitate Cell & Gene Therapy World 2017 - GlobeNewswire (press release) (NASDAQ:AGTC)
globenewswire.com - January 12 at 8:27 PM
finance.yahoo.com logoAGTC to Present at Phacilitate Cell & Gene Therapy World 2017 (NASDAQ:AGTC)
finance.yahoo.com - January 12 at 3:26 PM
finance.yahoo.com logoImplied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options (NASDAQ:AGTC)
finance.yahoo.com - January 12 at 3:26 PM
News IconStock Reaching Most Volatile List Today: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Wall Street Beacon (NASDAQ:AGTC)
wsbeacon.com - January 11 at 3:39 PM
News IconApplied Genetic Technologies Corp. (AGTC) Stock Moves Down ... - BNB Daily (blog) (NASDAQ:AGTC)
www.baseball-news-blog.com - January 10 at 3:26 PM
News IconApplied Genetic Technologies Corporation (AGTC) Valuation According To Analysts - UK Market News (NASDAQ:AGTC)
www.ukmarketnews.co.uk - January 5 at 3:30 PM
investornewswire.com logoSentiments And Ratings Alert: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Investor Newswire (NASDAQ:AGTC)
www.investornewswire.com - January 4 at 3:28 PM
News IconTop Stock With Upside & Growth Potential: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Prospect Journal (NASDAQ:AGTC)
prospectjournal.com - December 26 at 3:22 PM

Social

What is Applied Genetic Technologies Corporation's stock symbol?

Applied Genetic Technologies Corporation trades on the NASDAQ under the ticker symbol "AGTC."

Where is Applied Genetic Technologies Corporation's stock going? Where will Applied Genetic Technologies Corporation's stock price be in 2017?

7 brokerages have issued 1-year price objectives for Applied Genetic Technologies Corporation's shares. Their predictions range from $11.00 to $18.00. On average, they anticipate Applied Genetic Technologies Corporation's share price to reach $14.67 in the next twelve months.

When will Applied Genetic Technologies Corporation announce their earnings?

Applied Genetic Technologies Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

Who owns Applied Genetic Technologies Corporation stock?

Applied Genetic Technologies Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Interwest Venture Management Co. (8.04%), FMR LLC (6.18%), State Street Corp (1.67%), Eventide Asset Management LLC (1.54%), AQR Capital Management LLC (1.18%) and Oxford Asset Management (1.03%). Company insiders that own Applied Genetic Technologies Corporation stock include Ivana Magovcevic, Jeffrey D Chulay, Lawrence E Bullock, Mark S Shearman, Plc Glaxosmithkline and Stephen W Potter.

Who sold Applied Genetic Technologies Corporation stock? Who is selling Applied Genetic Technologies Corporation stock?

Applied Genetic Technologies Corporation's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Allianz Asset Management AG and Oxford Asset Management.

Who bought Applied Genetic Technologies Corporation stock? Who is buying Applied Genetic Technologies Corporation stock?

Applied Genetic Technologies Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Interwest Venture Management Co., AQR Capital Management LLC, Russell Investments Group Ltd., GSA Capital Partners LLP, Perceptive Advisors LLC, Dimensional Fund Advisors LP, Trexquant Investment LP and FMR LLC. Company insiders that have bought Applied Genetic Technologies Corporation stock in the last two years include Ivana Magovcevic, Lawrence E Bullock, Mark S Shearman and Stephen W Potter.

How do I buy Applied Genetic Technologies Corporation stock?

Shares of Applied Genetic Technologies Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Applied Genetic Technologies Corporation stock cost?

One share of Applied Genetic Technologies Corporation stock can currently be purchased for approximately $8.10.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Earnings History Chart

Earnings by Quarter for Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Dividend History Chart

Dividend Payments by Quarter for Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Last Updated on 2/19/2017 by MarketBeat.com Staff